Resolve Digital Health builds a smart medical cannabis delivery system, Breeze, paired with a cloud-based health information platform. Breeze delivers accurate, metered doses via pre-packaged single-use pods containing cannabis buds or oil, aiming to establish a standard of care. The company targets patients with cancer, arthritis, migraine, chronic pain and other conditions. After over two years of R&D, Resolve planned initial availability of its complete product ecosystem in Spring 2017 in select U.S. dispensaries. CannaRoyalty has provided seed capital, resources and multiple share acquisitions to support Resolve's research and development since its initial investment in October 2015. The company is positioned to commercialize its device-driven, measurable treatment solution for medical cannabis.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2017